3.10Open3.10Pre Close0 Volume15 Open Interest7.50Strike Price0.00Turnover6125.35%IV-2.20%PremiumMay 17, 2024Expiry Date3.87Intrinsic Value100Multiplier-2DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type-0.8884Delta0.1057Gamma0.92Leverage Ratio-6.9456Theta0.0000Rho-0.82Eff Leverage0.0001Vega
Cardiff Oncology Stock Discussion
In a significant development that has caught the attention of investors, Cardiff Oncology Inc. (NASDAQ: CRDF) saw an impressive 24% surge in their stock price yesterday, closing at $3.58. This sudden upswing comes amidst positive sentiments from leading investment banking and institutional securities firm, Piper Sandler, which has set a bullish price target of ...
🤘🏻
Cardiff Oncology (NASDAQ: $CRDF), a clinical-stage biotechnology company, has just reported its fourth quarter results. The company beat analyst consensus estimates on both earnings and revenue, marking a significant milestone in its financial performance. $Cardiff Oncology(CRDF.US)$
https://stockregion.app/p/clinical-stage-oncology-company-beats
No comment yet